Refractory T Lymphoblastic Leukemia/Lymphoma
1 clinical trials · Condition
◉ Watch Refractory T Lymphoblastic Leukemia/Lymphoma
| Record | Firm | Date |
|---|---|---|
| Multi-centers, Open-Label, Phase 2 Study to Evaluate the Efficacy and Safety of Donor-Derived CD7 CAR T Cells in Subjects With Relapsed or Refractory T-cell Leukemia/Lymphoma (NCT04689659) | Beijing Boren Hospital | 2021-12-01 |
Track Refractory T Lymphoblastic Leukemia/Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.